Pairing INH with HAART more effective

A new report from Johns Hopkins shows that pairing a common tuberculosis drug, isoniazid, with highly active antiretroviral therapy (HAART) is more effective than either therapy on its own at preventing full-blown TB disease in people with HIV.
In the Hopkins survey, sicker patients - those with immune cell CD4 counts of less than 350 per cubic milliliter of blood - were found to benefit more, with a 66 percent reduced risk of TB, compared to those with higher CD4 counts, whose risk went down by 56 percent.